Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response

Vaccine

Volumn 13, Issue 2, 1995, Pages 185-190

  Tomoda, Takashi ^a   Morita, Hideo ^a   Kurashige, Takanobu ^a   Maassab, Hunein F ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Cold recombinant; influenza vaccine; interferon ; intranasal administration; live attenuated; local IgA

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A; INFLUENZA VACCINE; INTERLEUKIN 2; LIVE VACCINE; RECOMBINANT VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; HUMAN; INFLUENZA; INTRANASAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VACCINATION;

ADMINISTRATION, INTRANASAL; ADULT; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNOGLOBULIN A; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; QUESTIONNAIRES; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 0028893571     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)93134-U     Document Type: Article

References (35)

1. Reinfection with influenza A (H2N2, H3N2, and H1N1) viruses in soldiers and students in Japan
2. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985
3. Consideration of the risk of influenza in children and indications for prophylaxis
4. Pneumonia and influenza deaths during epidemics: implications for prevention
5. Amplification, expression and packaging of a foreign gene by influenza virus
6. Introduction of site-specific mutations into the genome of influenza virus
7. Advantage of live-attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80(H3N2) wild-type virus infection
8. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine
9. Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines
10. Response of seronegative and seropositive adult volunteers to live attenuated cold-adapted reassortant influenza A virus vaccine
11. Comparison of heterotypic protection against influenza A/Taiwan/86(h1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses
12. Adaptation in growth characteristics of influenza virus at 25°C
13. Evaluation of a cold-recombinant influenza virus vaccine in ferrets
14. Comparative studies of wild-type and cold mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25°C between recent H3N2 and H1N1 epidemic strain and cold-adapted A/Ann Arbor/6/60
15. Pilot studies on recombinant cold-adapted live type A and B12 influenza virus vaccines
16. Acute respiratory disease associated with influenza epidemics in Houston 1981–1983
17. Influenza in children. Relationship to other respiratory agents
18. Influenza immunization policies and practices in Japan
19. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus
20. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus
21. Prevention and control of influenza: recommendation of the Immunization Practices Advisory Committee
22. Efficacy of influenza vaccine in nursing homes, reduction in illness and complications during an influenza A (H3N2) epidemic
23. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific
24. Cytotoxic T cell immunity to influenza
25. Antiviral cytotoxic T lymphocyte induction and vaccination
26. The recovery of mice from influenza virus infection: adoptive transfer of immunity with immune T lymphocytes
27. Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults
28. Human interferon alpha and gamma production by lymphocytes during the generation of influenza virus-specific cytotoxic T lymphocytes
29. A virus inhibitor in pharnygeal washings from patients influenza
30. Production of interferon in volunteers infected with asian influenza
31. Interferon production in children with respiratory syncytial influenza virus infection
32. Cell-mediated immune response of human lymphocytes to influenza A/USSR (H1N1) virus infection
33. Blastogenic lymphocyte response as indicator of cell-mediated immunity in humans vaccinated with live and inactivated influenza vaccines
34. Humoral and cellular response in humans after immunization with influenza vaccine
35. Influence of prior cellular immunity on the in vitro lymphocyte response to virus antigens after influenza vaccination